130 related articles for article (PubMed ID: 2219586)
1. Enhanced in vivo cytotoxicity of recombinant human tumor necrosis factor with etoposide in human renal cell carcinoma. Evaluation in a pre-clinical model.
Donaldson JT; Keane TE; Poulton SH; Walther PJ
Urol Res; 1990; 18(4):245-50. PubMed ID: 2219586
[TBL] [Abstract][Full Text] [Related]
2. Treatment of a human renal cell carcinoma in nude mice with recombinant human tumor necrosis factor alpha and etoposide.
Hofmockel G; Bassukas ID; Heimbach D; Wirth M; Maurer-Schultze B
J Urol; 1993 Dec; 150(6):1974-9. PubMed ID: 8230548
[TBL] [Abstract][Full Text] [Related]
3. Enhanced anti-tumor effects of recombinant human tumor necrosis factor plus VP-16 on metastatic renal cell carcinoma in a xenograft model.
Burgers JK; Marshall FF; Isaacs JT
J Urol; 1989 Jul; 142(1):160-4. PubMed ID: 2733097
[TBL] [Abstract][Full Text] [Related]
4. Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice.
Maurer-Schultze B; Bassukas ID; Hofmockel G
Cell Mol Biol (Noisy-le-grand); 1995 Feb; 41(1):65-78. PubMed ID: 7773138
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human tumor necrosis factor alone and with chemotherapeutic agents. Effect on nude mouse-supported human bladder cancer heterografts.
Das AK; Walther PJ; Buckley NJ; Poulton SH
Arch Surg; 1989 Jan; 124(1):107-10. PubMed ID: 2910237
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative and cytotoxic effects of single and combined treatment with tumor necrosis factor alpha and/or alpha interferon on a human renal cell carcinoma xenotransplanted into nu/nu mice: cell kinetic studies.
Baisch H; Otto U; Klöppel G
Cancer Res; 1990 Oct; 50(19):6389-95. PubMed ID: 2400997
[TBL] [Abstract][Full Text] [Related]
7. [Studies on anti-tumor activity of tumor necrosis factor alpha against human renal cell carcinoma cells heterotransplanted into nude mice].
Shibayama T; Tachibana M; Tazaki H; Nakamura K
Nihon Hinyokika Gakkai Zasshi; 1991 Oct; 82(10):1611-9. PubMed ID: 1770700
[TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy of metastatic renal cell cancer].
Manseck A; Wirth M
Urologe A; 1993 Sep; 32(5):360-73. PubMed ID: 7692655
[TBL] [Abstract][Full Text] [Related]
9. [In vivo anti-tumour efficacy of tumour necrosis factor and interferon- alpha, -gamma on human renal cell carcinoma heterotransplanted in nude mice].
Onishi T; Machida T; Masuda F; Iizuka N; Nakauchi K; Furuta N; Shirakawa H
Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1571-8. PubMed ID: 2121869
[TBL] [Abstract][Full Text] [Related]
10. Immunochemotherapy for murine bladder tumor with a new human recombinant tumor necrosis factor (rTNF-S), VP-16 and hyperthermia.
Iizumi T; Yazaki T; Waku M; Soma G
J Urol; 1989 Aug; 142(2 Pt 1):386-9. PubMed ID: 2746758
[TBL] [Abstract][Full Text] [Related]
11. [Anti-tumor effect of human recombinant tumor necrosis factor on the human renal cell carcinoma serially transplanted into nude mice].
Honda N; Yamada Y; Muramatsu T; Fukatsu H; Segawa A
Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1613-21. PubMed ID: 3251094
[No Abstract] [Full Text] [Related]
12. Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.
Bassukas ID; Hofmockel G; Maurer-Schultze B
Anticancer Res; 1994; 14(1A):237-45. PubMed ID: 8166454
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of monoclonal antibody G250, interferons and tumor necrosis factor, in mice with renal-cell carcinoma xenografts.
van Dijk J; Uemura H; Beniers AJ; Peelen WP; Zegveld ST; Fleuren GJ; Warnaar SO; Oosterwijk E
Int J Cancer; 1994 Jan; 56(2):262-8. PubMed ID: 8314310
[TBL] [Abstract][Full Text] [Related]
14. In vivo effects of recombinant human lymphotoxin on human medulloblastoma xenograft: enhancement of antitumor activity of etoposide.
Mikami T; Uozumi T; Kurisu K; Kawamoto K; Kiya K; Hotta T
Biotherapy; 1994; 8(1):7-17. PubMed ID: 7547084
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas.
Hoon DS; Okun E; Banez M; Irie RF; Morton DL
Cancer Res; 1991 Oct; 51(20):5687-93. PubMed ID: 1913686
[TBL] [Abstract][Full Text] [Related]
16. The current use of interferons, interleukin-2 and tumor necrosis factor in renal cell cancer.
Wirth M
Urol Int; 1991; 47(4):219-30. PubMed ID: 1723554
[TBL] [Abstract][Full Text] [Related]
17. Effect of alpha-interferon alone and combined with other antineoplastic agents on renal cell carcinoma determined by the tetrazolium microculture assay.
Homma Y; Aso Y
Eur Urol; 1994; 25(2):164-70. PubMed ID: 8137859
[TBL] [Abstract][Full Text] [Related]
18. [Anti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma line].
Gohji K; Hamami G; Kamidono S
Hinyokika Kiyo; 1987 Mar; 33(3):329-35. PubMed ID: 3113191
[TBL] [Abstract][Full Text] [Related]
19. In vitro antiproliferative efficacy of interferon-alpha, -gamma and tumor necrosis factor on two human renal tumor xenografts.
Beniers AJ; Peelen WP; Hendriks BT; Schalken JA; Romijn JC; Debruyne FM
Urol Res; 1988; 16(4):309-14. PubMed ID: 2459829
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of tumor necrosis factor alpha and anticancer chemotherapeutic agents against human renal carcinoma cell lines.
Ikemoto S; Hayahara N; Wada S; Nishio S; Maekawa M
Eur Urol; 1991; 19(3):236-9. PubMed ID: 1855530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
